Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002262000 | SCV002542786 | uncertain significance | Autoinflammatory syndrome | 2022-04-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003101467 | SCV003519562 | pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2024-12-16 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 168 of the PRF1 protein (p.Ser168Asn). This variant is present in population databases (rs779399414, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of hemophagocytic lymphohistiocytosis (PMID: 20092789, 21674762, 25233452, 29357941, 29665027, 31388699). ClinVar contains an entry for this variant (Variation ID: 1694131). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PRF1 protein function with a negative predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV003134408 | SCV003809861 | uncertain significance | not provided | 2021-12-14 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003475317 | SCV004204173 | likely pathogenic | Aplastic anemia | 2024-03-30 | criteria provided, single submitter | clinical testing |